SCM
OCUL icon

Sio Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Sio Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.3M Sell
539,493
-429,104
-44% -$3.89M 0.88% 35
2026
Q1 		$8.2M Buy
+968,597
New +$9.23M 1.18% 32
2024
Q2 		– Sell
-383,026
Closed -$3.49M – 60
2024
Q1 		$3.49M Sell
383,026
-588,420
-61% -$4.18M 1.04% 28
2023
Q4 		$4.33M Buy
+971,446
New +$2.87M 0.99% 19
2019
Q3 		– Sell
-59,668
Closed -$263K – 79
2019
Q2 		$263K Buy
+59,668
New +$221K 0.06% 69

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sio Capital Management's OCUL Position: Q2 2026 in Review

Sio Capital Management reduced its Ocular Therapeutix (OCUL) stake by 44% in Q2 2026, selling an estimated $3.89M and leaving 539,493 shares worth $5.3M. The position accounts for 0.88% of the portfolio, ranked #35.

Sio Capital Management first reported a position in OCUL in Q2 2019 and has held it in 5 quarters since. The position peaked at $8.2M in Q1 2026. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Sio Capital Management held 539,493 shares of Ocular Therapeutix worth $5.3M as of Q2 2026.
  • Sio Capital Management sold 429,104 Ocular Therapeutix shares in Q2 2026, an estimated $3.89M.
  • Ocular Therapeutix made up 0.88% of Sio Capital Management's portfolio in Q2 2026, its #35 holding.
  • Sio Capital Management first reported a position in Ocular Therapeutix in Q2 2019 and has held it in 5 quarters since.
  • Sio Capital Management's Ocular Therapeutix position peaked at $8.2M in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.